AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇸🇳
METAMIZOLE in Senegal
6 products registered with ARP — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| RESTRIVA ampoule injectable / 500 mg / ml | 5603 | TROIKAA PHARMACEUTICALS LIMITED | active | — |
| CALGIN comprimé / 500 mg | UNKNOWN-6e6b6286 | CAPLIN LABORATOIRE | active | — |
| METAGEN comprimé / 500mg | UNKNOWN-0a582b53 | GENERIC HEALTH CARE PVT. LTD | active | — |
| CALGIN comprimé / 500 mg | UNKNOWN-d694b473 | CAPLIN LABORATOIRE | active | — |
| RESTRIVA comprimé / 500 mg | 5602 | TROIKAA PHARMACEUTICALS LIMITED | active | — |
| METAGEN comprimé / 500mg | UNKNOWN-190d3f9c | GENERIC HEALTH CARE PVT. LTD | active | — |
METAMIZOLE — ARP Registration Details
ARP (Senegal) has 6 registered products containing METAMIZOLE, of which 6 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track METAMIZOLE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.